Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new

For metastatic soft tissue sarcoma (STS) patients not eligible for surgery, systemic treatments, including standard chemotherapy and newer biological compounds, still play the most relevant role in the management of the disease. An anthracycline and alkylating agent combination has formed the corner...

Descripción completa

Detalles Bibliográficos
Autores principales: Frezza, Anna Maria, Stacchiotti, Silvia, Gronchi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455204/
https://www.ncbi.nlm.nih.gov/pubmed/28571564
http://dx.doi.org/10.1186/s12916-017-0872-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455204/
https://www.ncbi.nlm.nih.gov/pubmed/28571564
http://dx.doi.org/10.1186/s12916-017-0872-y

Ejemplares similares